These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 13342507)
21. Current status of aryl sulfonylureas in treatment of diabetes mellitus. DAVIDSON JW; UNGER RH J Am Med Assoc; 1956 Sep; 162(5):447-53. PubMed ID: 13357329 [No Abstract] [Full Text] [Related]
22. Clinical experience and experimental studies with tolbutamide. CRAIG JW; MILLER M Diabetes; 1957; 6(3):280-2; discussion, 282-9. PubMed ID: 13427636 [No Abstract] [Full Text] [Related]
23. [Experiences on 1,000 diabetics treated with sulfonylureas (BZ 55 and D 860)]. BERTRAM F Gaz Med Fr; 1957 Mar; 64(6):519-24. PubMed ID: 13427958 [No Abstract] [Full Text] [Related]
24. Sulfonylureas and diabetes mellitus. I. Clinical evaluation. COX RW; FERGUS EB; HENLEY ED; WILLIAMS RH Diabetes; 1956; 5(5):358-65. PubMed ID: 13365475 [No Abstract] [Full Text] [Related]
25. Treatment of diabetes mellitus with BZ-55. CHARLES B Can Med Assoc J; 1956 Jun; 74(12):985-7. PubMed ID: 13329951 [No Abstract] [Full Text] [Related]
26. Treatment of diabetes mellitus with BZ-55. METZLER WS Can Med Assoc J; 1956 Jun; 74(12):987-8. PubMed ID: 13329952 [No Abstract] [Full Text] [Related]
27. [Examination of steroids in therapy with N'-sulfanilyl-N2-N-butylcarbamid (nadisan)]. RAUSCH-STROOMANN JG; SAUER H Klin Wochenschr; 1956 Jul; 34(25-26):707-8. PubMed ID: 13347046 [No Abstract] [Full Text] [Related]
28. Present state of knowledge concerning effects of the sulfonylurea compounds in diabetes mellitus; report of the Committee on Summarization of the Conference. KRAHL ME; LUKENS FD; RICKETTS HT Diabetes; 1957; 6(1):91-2. PubMed ID: 13397436 [No Abstract] [Full Text] [Related]
29. Diabetes mellitus. BERNHARD H Indian J Med Sci; 1957 Feb; 11(2):59-63. PubMed ID: 13428303 [No Abstract] [Full Text] [Related]
30. The hypoglucemic sulfonylurea drugs; an interim evaluation. STETTEN D Ann Intern Med; 1957 May; 46(5):1005-8. PubMed ID: 13411912 [No Abstract] [Full Text] [Related]
31. Clinical use of oral sulfonylurea compounds in diabetes mellitus. COLWELL AR; COLWELL JA Q Bull Northwest Univ Med Sch; 1957; 31(2):102-13. PubMed ID: 13453644 [No Abstract] [Full Text] [Related]
32. Treatment of unstable diabetes mellitus with BZ-55 and insulin. WATT JG Can Med Assoc J; 1956 Jun; 74(12):983-5. PubMed ID: 13329950 [No Abstract] [Full Text] [Related]
33. Clinical response to BZ-55. SPAULDING WB Can Med Assoc J; 1956 Jun; 74(12):992-4. PubMed ID: 13329955 [No Abstract] [Full Text] [Related]
34. [First results of the treatment of diabetes by BZ 55]. Klotz HP; Avril J; Israel L; Gorins L Bull Mem Soc Med Hop Paris; 1956; 72(14-15):453-5. PubMed ID: 13342945 [No Abstract] [Full Text] [Related]
35. [Results and clinical aspects of new oral treatment of diabetes mellitus with N-butylsulfanilylurea BZ-55]. INTROZZI P; MARIGO S Minerva Med; 1956 Jun; 47(50):1959-66. PubMed ID: 13348335 [No Abstract] [Full Text] [Related]
36. Preliminary experience with BZ-55. HALL WE; LITTLE JA; O'SULLIVAN MO Can Med Assoc J; 1956 Jun; 74(12):991-2. PubMed ID: 13329954 [No Abstract] [Full Text] [Related]
37. Clinical effects of BZ-55 (carbutamide). CHASE LA Can Med Assoc J; 1956 Jun; 74(12):989-90. PubMed ID: 13329953 [No Abstract] [Full Text] [Related]
38. Oral treatment of diabetes mellitus with the sulfonamide BZ-55. HERNBERG CA Acta Endocrinol (Copenh); 1956 Nov; 23(3):281-8. PubMed ID: 13381391 [No Abstract] [Full Text] [Related]